Copyright
©The Author(s) 2017.
World J Cardiol. Dec 26, 2017; 9(12): 830-837
Published online Dec 26, 2017. doi: 10.4330/wjc.v9.i12.830
Published online Dec 26, 2017. doi: 10.4330/wjc.v9.i12.830
Figure 1 Process of study selection for randomized and prospective trials (PRISMA Statement).
Figure 2 Forest plot demonstrating the primary and secondary outcomes in patients with out of hospital cardiac arrest who received erythropoietin compared to no erythropoietin group.
A: Primary Outcomes: Brain death or CPC score 5; B: Secondary outcome: CPC score 1, and 2-4; C: Secondary outcome: Thrombotic events and acute stent thrombosis.
- Citation: Chaudhary R, Garg J, Krishnamoorthy P, Bliden K, Shah N, Agarwal N, Gupta R, Sharma A, Kern KB, Patel NC, Gurbel P. Erythropoietin therapy after out-of-hospital cardiac arrest: A systematic review and meta-analysis. World J Cardiol 2017; 9(12): 830-837
- URL: https://www.wjgnet.com/1949-8462/full/v9/i12/830.htm
- DOI: https://dx.doi.org/10.4330/wjc.v9.i12.830